Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
TRK Inhibitor Active in Treatment-Refractory Glioblastoma
2.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer
5.
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets
1.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
2.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
3.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
4.
The Capmist DM: A Revolutionary Way to Combat Dry Mouth
5.
Hypercoagulable State: Factors that Contribute to Blood Clots
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation